Does the regional use of intensive chemotherapy impact the outcome of adults with AML?

Saved in:
Bibliographic Details
Main Author: Corentin Orvain
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000480.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581938226921472
author Corentin Orvain
author_facet Corentin Orvain
author_sort Corentin Orvain
collection DOAJ
format Article
id doaj-art-272fb9aa730b4c8f9c450c8f56772d13
institution Kabale University
issn 2752-7948
language English
publishDate 2024-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Oncology
spelling doaj-art-272fb9aa730b4c8f9c450c8f56772d132025-01-30T07:30:09ZengBMJ Publishing GroupBMJ Oncology2752-79482024-12-013110.1136/bmjonc-2024-000480Does the regional use of intensive chemotherapy impact the outcome of adults with AML?Corentin Orvain0Angers University Hospital, Angers, Francehttps://bmjoncology.bmj.com/content/3/1/e000480.full
spellingShingle Corentin Orvain
Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
BMJ Oncology
title Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
title_full Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
title_fullStr Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
title_full_unstemmed Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
title_short Does the regional use of intensive chemotherapy impact the outcome of adults with AML?
title_sort does the regional use of intensive chemotherapy impact the outcome of adults with aml
url https://bmjoncology.bmj.com/content/3/1/e000480.full
work_keys_str_mv AT corentinorvain doestheregionaluseofintensivechemotherapyimpacttheoutcomeofadultswithaml